Morgan Stanley (NYSE:MS) analyst Tejas Savant maintained a Hold rating on Berkeley Lights on Wednesday, setting a price target of $73, which is approximately 69.26% above the present share price of $43.13.
Savant expects Berkeley Lights to post earnings per share (EPS) of -$0.19 for the second quarter of 2021.
The current consensus among 1 TipRanks analysts is for a Hold rating of shares in Berkeley Lights, with an average price target of $73.
The analysts price targets range from a high of $73 to a low of $73.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $21.75 million and a net profit of -$11.83 million. The company's market cap is $2.86 billion.
According to TipRanks.com, Morgan Stanley analyst Tejas Savant is currently ranked with 1 stars on a 0-5 stars ranking scale, with an average return of 0.0% and a 46.88% success rate.
Berkeley Lights Inc is a digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The Berkeley Lights platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. The Berkeley Lights Platform is a fully integrated, end-to-end solution, comprised of proprietary consumables, including its OptoSelect chips and reagent kits, advanced automation systems and advanced application and workflow software. The company operates in North America, Asia Pacific and Europe, with North America deriving majority of the revenue.